Concepedia

Author

Lingfan Xu

First Affiliated Hospital of Anhui Medical UniversityORCID

Also Known As

L L Xu, L Xu, Ling-Fan Xu, Lingfan Xu, Storey, Aaron J, Xu, Lingfan

58

Publications

1.1K

Citations

17

H-Index

57

Concepts

All Affiliations

First Affiliated Hospital of Anhui Medical UniversityAnhui Medical UniversityDuke UniversitySecond Military Medical UniversityChanghai Hospital
LX

About

Lingfan Xu is an author at First Affiliated Hospital of Anhui Medical University specializing in medicine, tumor biology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

387

2

Cell Biology

5

5

283

3

Engineering

1

1

19

4

Natural Sciences

1

1

48

5

Public Health

1

1

16

Lingfan Xu

×

23

Publications

968

Citations

16

H-Index

YearCitations

Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance

Su Deng, Choushi Wang, Yunguan Wang,

Nature Cancer

2022

138

Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer

Yanjing Li, Yiping He, William Butler,

Science Translational Medicine

2019

135

N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway

Yu Yin, Lingfan Xu, Yan Chang,

Molecular Cancer

2019

120

A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer

Lingfan Xu, Yu Yin, Yanjing Li,

Proceedings of the National Academy of Sciences

2021

68

Long Non-Coding RNA SNHG1 Regulates the Wnt/β-Catenin and PI3K/AKT/mTOR Signaling Pathways via EZH2 to Affect the Proliferation, Apoptosis, and Autophagy of Prostate Cancer Cell

Junyi Chen, Fubo Wang, Huan Xu,

Frontiers in Oncology

2020

65

Cistrome analysis of YY1 uncovers a regulatory axis of YY1:BRD2/4-PFKP during tumorigenesis of advanced prostate cancer

Chenxi Xu, Yi‐Hsuan Tsai, Phillip M. Galbo,

Nucleic Acids Research

2021

48

Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC

Yaqun Zhang, Lingfan Xu, Yan Chang,

Prostate Cancer and Prostatic Diseases

2019

44

N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells

Yi Sun, Jun Jing, Huan Xu,

Journal for ImmunoTherapy of Cancer

2021

41

MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing

Li Zhang, Pengfei Wei, Xudong Shen,

PLoS ONE

2015

38

ATM deficiency promotes progression of CRPC by enhancing Warburg effect

Lingfan Xu, Enze Ma, Tao Zeng,

Endocrine Related Cancer

2018

34

Page 1